Browse > Article
http://dx.doi.org/10.13048/jkm.13018

Effects of Bogijetong-Tang on Diabetic-peripheral Neuropathy Induced by Streptozotocin in the Mouse  

Lee, Jong Bin (Dept. of Internal Medicine, College of Oriental Medicine, Dae-Jeon University)
Kim, Chul Jung (Dept. of Internal Medicine, College of Oriental Medicine, Dae-Jeon University)
Cho, Chung Sik (Dept. of Internal Medicine, College of Oriental Medicine, Dae-Jeon University)
Publication Information
The Journal of Korean Medicine / v.34, no.3, 2013 , pp. 126-142 More about this Journal
Abstract
Objectives: Previous reports have shown that Bogijetong-Tang (BJT) is effective in peripheral neuropathy induced by taxol and crush injury. In this study, we researched the effects of BJT on diabetic neuropathy induced by STZ in the mouse. Methods: We performed both in vitro and in vivo experiments to verify the effects of BJT on diabetic neuropathy induced by STZ in mice. Changes in axonal recovery were observed with immunofluorescence staining using NF-200, Hoechst33258, $S100{\beta}$, caspase 3 and anti-cdc2. Proliferation and degeneration of Schwann cells were investigated by immunofluorescence staining and western blot analyses. Results: BJT showed considerable effects on neurite outgrowth and axonal regeneration in diabetic neuropathy. BJT contributed to the creation of NF-200, GAP-43, Cdc2, phospho-vimentin, ${\beta}1$, active ${\beta}1$, ${\beta}3$ integrin, phospho-Erk1/2 protein. Conclusions: Through this study, we found that BJT is effective for enhanced axonal regeneration via dynamic regulation of regeneration-associated proteins. Therefore, BJT had a pharmaceutical property enhancing recovery of peripheral nerves induced by diabetic neuropathy and could be a candidate for drug development after more research.
Keywords
Diabetic-peripheral neuropathy; Bogijetong-Tang (BJT); sciatic nerve; Schwann cell; dorsal root ganglia;
Citations & Related Records
연도 인용수 순위
  • Reference
1 The Whole Country College Korean Medicine, Department of Singye Internal Medicine. Singye Internal Medicine. Seoul:Koonja publishing co.. 2011:310.
2 Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes. 1999;7:245-52.
3 Kathleen M, Halat, Cathi E, Dennehy, Pharm D. Botanicals and Dietary Supplements in Diabetic Peripheral Neuropathy. J Am Board Fam Pract. 2003;16(1):47-57.   DOI
4 Kinoshita JH, Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes Metab. 1988;4:323-37.   DOI
5 Kaul CL, Ramarao P. The role of aldose reductase inhibitions in diabetic complications: recent trends. Methods Find Exp Clin Phamacol. 2001;23:465-75.   DOI
6 Green DA, Lattimer SA, Sima AF. Sorbitol, phosphoi nositides and sodium-potassium ATPase in the pathogenesis of diabetic complication. The New England Journal of medicine. 1987;316(10):599-606.   DOI
7 Korean Diabetes Association, Group for Research on Neuropathy. Diabetic Neuropathy. Seoul:Gold Gihoek. 2006:172-3.
8 Dyck PJ. Detection, characterization and staging of polyneuropathy: assessed in diabetes. Muscle & Nerve. 1988;11(1):21-32.   DOI
9 Kim JM, Cho CS, Kim CJ. Overview of Diabetic Peripheral Neuropathy and Need for Therapeutic Strategy using Traditional Korean Medicine. J Korean Oriental Med. 2009:30(5)127-36.
10 Chen YS. Wu CH,YAO CH, Chen CT. Ginsenoside Rb-1 enhance peripheral nerve regeneration across wide gaps in silicone rubber chambers. Int J Artif Organ. 2002;Nov;25(11):1103-8.
11 Kang SB. 2 case of Diabetic Neuropathy Treatments. J Korean Oriental Med. 1992;13(2): 22-5.
12 Park SW, Kang JK, Moon SK, Ko CN. Two experiences of the treatment for diabetic peripheral neuropathy. Journal of Korean Oriental Chronic Disease. 1997;3(1):251-8.
13 Cho KH, Jung S, Lee KJ. A Case of Yukmijihwanghwan's effect on Diabetic neuropathy. Korean J. Orient. Int. Med. 1999; 20(1):286-90.
14 Kwon YK, Choi KR, Lee JS, Lee BC, Ahn YM, Ahn SY, et al. Two Cases of Diabetic Peripheral Polyneuropathy Improved by Bogan-tang. J Korean Oriental Med. 2002;23(1):170-7.
15 Park SK, Kwon EH, Shin HC, Kang SB. One case of Diabetic Peripheral Polyneuropathy Improved by Binsosan-gamibang. J Korean Oriental Med. 2005:26(4):935-40.
16 Choi HS, Cho CS, Kim CJ. Clinical Study on Two Cases of In patients with Diabetic Peripheral Neuropathy. Daejeon University Institute of korean medicine thesis Collection. 2004;13(2)251-8.
17 Kim JM, Cho CS, Kim CJ.. Clinical Study of 8 Diabetic Patients with Paresthesia. Korean J. Orient. Int. Med. 2010:31(2)184-91.
18 An SH. Effects of Bogijetong-tang treatment on animal model of peripheral neuropathy induced by Taxol and crush injury. Doctoral Dissertation. Daejeon:Daejeon Univ.;2012.
19 Banker G, Goslin K. Culturing nerve cells. MIT press. 2002.
20 Felderman EL, Russell JW, Sullivan KA, Golovoy D. New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neurol. 1999; 12:553-63.   DOI
21 Greene DA, Sima AA, Stevens MJ, Felderman EL, Lattimer SA. Complication: neuropathy, pathogenetic consideration. Diabetes Cares. 1992;15:1902-25.   DOI
22 Verrotti A, Giuva PT, Morgese G, Chiarelli F. New trends in the etiopathogenesis of diabetic peripheral neuropathy. J Child Neurol. 2001;16: 389-94.
23 Stevens MJ, Felderman EL, Greene DA. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet Med. 1995;12:566-79.   DOI
24 Greene DA, Lewis RA, Lattimer SA, Brown MJ. Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin-diabetic rat. Diabetes. 1982;31:573-8.   DOI
25 Brownlee M, Vlassara H, Cerami A. Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes. Diabetes. 1984;33:532-5.   DOI
26 Tilton RG, Chang K, Nyengaard JR, Van den Enden M, Ido Y, Williamson JR. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozotocin induced diabetic rats. Diabetes. 1995;44:234-42.   DOI
27 Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, et al. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 1995;18:1160-7.   DOI
28 Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR. Effects of antioxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia. 1995;38:129-134.   DOI
29 Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes. 1997;2:S31-7.
30 Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, et al. Prevention of abnormalities in motor nerve conduction and nerve bloodflow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats. Prostaglandins. 1995;49:339-49.
31 Hounsom L, Horrobin DF, Tritschler H, Corder R, Tomlinson DR. A lipoic acid-gamma linolenic acid conjugate ie effective against multiple indices og experimental diabetic neuropathy. Diabetologia. 1998;41:839-43.   DOI
32 A society for the research of Neuropathy in Korean Diabetes Association. Clinical practice of diabetic neuropathy. 2nd ed. Seoul: Korean Diabetes Association. 2007:1-48.
33 Doo HK. Internal medicine of kidney in oriental medicine. Seoul :Institute of oriental medicine. 1991:969-76.